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Abstract 
Thyroid hormone regulates the in vivo expression of a selected set of rat nuclear genes encoding mitochondrial inner membrane 
proteins. Certain mRNAs, such as that for cytochrome c~, are increased as much as 20-50-fold, while others, such as core protein 1 of 
Complex III and the F~-ATPase /3-subunit do not respond. The promoter region of human cytochrome c t also supports thyroid hormone 
induction of a reporter gene in transient ransfection experiments. Thus, thyroid hormone regulates only selected genes, even for subunits 
within the same complex and in widely varying species. By contrast, growth activation of quiescent NIH3T3 cells, a second paradigm 
used for stimulating mitochondrial biogenesis, does not increase cytochrome c~ mRNA but does increase F~-ATPase /3-subunit mRNA. 
These findings suggest that nuclear OXPHOS genes are not necessarily expressed in a coordinated manner, and that multiple regulatory 
circuits might exist which are linked to different physiological stimuli. Analysis of the promoters of several OXPHOS genes reveals a 
great diversity and heterogeneity of transfactor binding elements. No single regulatory feature exists which could account for a 
coordinated expression of all OXPHOS genes. The potential diversity for regulating expression of nuclear OXPHOS genes raises the 
possibility for the existence of disease states linked to regulatory defects. 
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1. Introduction 
Most of the mitochondrial-based human diseases which 
have been described involve either deletions or point muta- 
tions of the mitochondrial genome [1]. Although the mito- 
chondrion is composed mostly of nuclear encoded pro- 
teins, surprisingly few nuclear mutations that effect mito- 
chondrial function have been identified. The reason for this 
is not known, but probably reflects to some extent he lack 
of efficient screening methods for identifying specific mu- 
tated nuclear genes. 
An additional group of potential mutants which could 
conceivably lead to a disease state are those affecting 
regulatory proteins, i.e., proteins which control mitochon- 
drial synthesis. However since little is known about the 
global regulation of mammalian mitochondrial biogenesis, 
no examples of such diseases have appeared to date. The 
search for regulatory mutations is hindered somewhat by 
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the widely accepted view that nuclear genes encoding 
mitochondrial proteins are 'constitutively expressed', and, 
therefore are not subject o regulated expression. However, 
the present paper argues that this is an oversimplification. 
Here we show that expression of nuclear encoded mito- 
chondrial proteins can be subject o a variety of regulatory 
circuits and that the promoters of such genes vary greatly 
in structure and potential regulatory features. In view of 
our current understanding of the promoters, there are strong 
reasons to expect a plethora of regulatory circuits which 
converge to express mitochondrial synthesis. 
2. Materials and methods 
Induction of hypothyroidism, injection of T3, and 
Northern blot analysis of rat liver transcripts are described 
in [2,3]. A fragment of the human cytochrome gene ex- 
tending 567 bp 5' of translation start was amplified by the 
polymerase chain reaction and cloned into pGEM or up- 
stream of the CAT reported gene in pCATbasic (Promega). 
A 1.4 kb genomic fragment containing the 5' flanking 
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Table 1 
Quantitative response of selected mRNAs to thyroid hormone 
mRNA Relative levels of transcripts detected by Northern blot 
hypothyroid hypo + T3 + T3 / -  T3 
Cytochrome c I 40 _+ 16 1155 _+ 236 28.9 
ANT2 95 + 49 1234 _+ 118 13.0 
DCCD-binding protein 323 _+ 27 1233 _+ 160 3.4 
F1-ATPase /3-subunit 1661 ___ 66 2843 _+ 612 1.7 
COX IV 956 _+ 69 1332 + 190 1.4 
COX I 402 _+ 134 1791 + 225 4.5 
Actin 636 _+ 113 1029 _+ 189 1.6 
Hypothyroid rats were given daily injections of T3 (20 izg/100 g) for 3 days. Densitometric scanning of Northern blots is described in Materials and 
methods, n = 4 for each sample. The data is adapted from Ref. [3]. 
region of human cytochrome c I [4] was kindly provided by 
Dr. T. Ozawa. All other constructs were created by remov- 
ing restriction fragments from the cloned inserts and reli- 
gating the original plasmid. Transient transfection and 
hormone treatment of JEG 3 cells is described in the 
legend to Fig. 4. 
3. Results and discussion 
3.1. General control of mitochondrial biogenesis 
The mitochondrial mass of individual cells differs with 
cell and tissue type. Furthermore, mitochondrial mass 
within a given cell type can be increased during cell 
differentiation, hormone treatment and exercise [5,6]. To 
date, the mechanisms underlying this regulation are virtu- 
ally unknown. Since the generation of new mitochondrial 
mass starts from existing organelles, biogenesis can be 
viewed as a process which merely activates expansion of 
the existing membranes. However, to achieve a shift in the 
levels of mitochondria within a cell, mitochondria mass 
must be made more rapidly than the rest of the cellular 
proteins (Fig. 1). Thus, to up-regulate mitochondrial mass 
the cell must preferentially express nuclear genes encoding 
mitochondrial proteins and/or the mitochondrial genes 
(Fig. 1). Furthermore, an induced shift in the 'steady state' 
level of mitochondria implies activation of a rate limiting 
process. Whether this rate limiting process lies in the 
expression of nuclear genes (Fig. 1), and, if so, which 
genes, is not known. 
3.2. The role of thyroid hormone and growth activation in 
regulating mitochondrial biogenesis 
Altered thyroid hormone status provides a useful 
paradigm for investigating the mechanisms regulating shifts 
in mitochondrial cellular mass (reviewed in Refs. [7,8]). In 
animal models, thyroid hormone regulates the number of 
mitochondrial profiles [10], and the area of the inner 
membrane and cytochrome content [5]. Mitochondrial tran- 
scription and translation are also increased by thyroid 
hormone [7-9]. This is achieved, however, by regulating 
only a few percent of the nuclear encoded mitochondrial 
inner membrane proteins [11] or the total cellular proteins 
[2]. 
In order to identify some of the hormone-responsive 
mitochondrial proteins, we investigated several compo- 
nents of the respiratory chain complexes [2,3]. Northern 
blot analysis indicates that the transcript levels of some, 
but not all, subunits of these complexes are greatly influ- 
enced by hormone status. This is exemplified in Fig. 2 for 
cytochrome c I mRNA. Table 1 summarizes the response 
of several genes tested. To date, Northern analysis show 
that the mRNAs of 3 nuclear genes (cytochrome c~, ANT2 
and subunit C of the F0-ATPase) are significantly in- 
creased by triiodothyronine (T3), while others (FI-/3 sub- 
unit, COXIV) are not. Cytochrome c has also been re- 
ported to respond to thyroid hormone [12]. 
The effects of T3 on transcript abundance was also 
measured by in vitro translation of mRNA present in the 
post mitochondrial fraction from the livers of hypothyroid 
and T3 treated rats [2]. This study [2] revealed a large 
response of cytochrome c~ to T3. In addition, the Reiske 
iron sulfur protein, but not core protein 1, of Complex III 
was induced. Transhydrogenase mRNA was slightly in- 
creased by T3, whereas the RNAs for the FI-ATPase 
/ ~on-rnitochonddal cell protein'] 
~*4ib', [Mitochond rial prot ein-I .~lp.. ~ - -  ~ 
[Mitochondr~ 
Fig. 1. General control of the steady state levels of mitochondria. To 
induce an increase in mitochondria on a cellular basis, mitochondrial 
mass must increase relative to other cellular components. An induced 
shift from one steady state level of mitochondria toa second level implies 
activation of a process which was previously limiting. This process could 
involve the activation of nuclear or mitochondrial gene expression, or 
both. A description of these 'rate limiting' processes i required in order 
to understand how tissue-specific mitochondrial levels are maintained, or 
how mitochondria are produced in large amounts during specific stages in 
the differentiation of certain cell types. 
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/3-subunit and /3-hydroxybutyrate dehydrogenase w re not 
influenced [2]. 
The above studies and studies by others [9] demonstrate 
clearly that the nuclear encoded components of the inner 
membrane are not co-ordinately regulated by thyroid hor- 
mone. Indeed, subunits of the same complex are not 
increased in a co-ordinate fashion. Much more striking, 
however, is the finding that hormone-regulated inner mem- 
brane proteins do not always respond to other factors 
which activate mitochondrial production; for example cell 
growth [13]. Table 2 summarizes this observation. Cy- 
tochrome q ,  though responsive to T3, in not influenced by 
serum activation of quiescent NIH3T3 cells, whereas the 
F~-ATPase /3-subunit, which is not responsive to hormone, 
is significantly increased by growth activation. ANT2, 
which was first identified as a growth response gene [14], 
is induced by both thyroid hormone and growth activation 
(Table 2). It should be noted, however, that expression of 
the mitochondrial genome is activated by both hormone 
[ 15] and growth stimulation [ ! 3,16] (Table 2). 
3.3. Characterization of the thyroid regulatoo' mechanism 
in the human cytochrome c z promoter 
thyroid hormone receptor (TR). This result indicates that 
T3 induction of cytochrome c 1 takes place via a TR-medi- 
ated mechanism. The results also demonstrate that hor- 
mone regulation of the cytochrome c~ gene occurs both in 
rats in vivo and with the human gene in vitro, implying a 
well conserved hormone regulatory mechanism for this 
gene. 
3.4. The regulatory features of the OXPHOS gene promot- 
ers vary dramatically 
The data discussed above lead to the unexpected con- 
clusion that subunits of the inner membrane are not neces- 
sarily co-ordinately expressed, not even those subunits of 
the same complex. Furthermore, since the response of an 
individual gene differs with the nature of the physiological 
stimuli, we conclude that multiple regulatory circuits exist 
for the individual genes. This idea is supported by the data 
summarized in Table 3. To date, four major cis response 
In order to further analyze the factors that regulate 
expression of cytochrome cl, which is the most highly 
T3-responsive mitochondrial gene identified to date, the 5' 
flanking region was amplify by the polymerase chain 
reaction and cloned. A large number of putative transfactor 
binding sites can be identified in this region, including 
those for SP1 [17], Ets [18], API [19], NF1 (nuclear factor 
1 [20]), NRF (nuclear espiratory factor) 1 [21] and 2 [22], 
Mt2 [23], RBE (retinoblastoma protein binding element 
[24]), and TRE (thyroid hormone receptor binding element 
[25]). To determine if hormone induction of cytochrome c 1 
expression in rats is due to induction of any of the above 
transfactors, the nuclear proteins from hypothyroid and T3 
injected rats were analyzed by the mobility shift assay 
using as probes a series of fragments covering different 
parts of the cytochrome c~ promoter region (Fig. 3). All of 
the probes were shifted, but the same complexes were 
formed by nuclear proteins from hypothyroid or T3 in- 
jected rats. The only possible xception was the occasional 
appearance of an extra band when the full length clone 
was used as the gel shift probe with nuclear proteins 
hyperthyroid livers. However, the combined ata suggests 
that T3 activation of cytochrome c~ does not involve 
hormone-dependent synthesis of new nuclear factors. 
The mechanism by which T3 controls cytochrome c~ 
expression was next investigated by transient transfection. 
For these experiments a 1.4 kb fragment of the 5' flanking 
region the human gene [4] was cloned in front of the CAT 
reporter gene and transfected into a human chorionocarci- 
noma cell line (JEG-3). The data in Fig. 4 demonstrate hat 
this fragment supports hormone induction of CAT activity 
if the cells are co-transfected with a plasmid expressing the 
-T3 +T3 
Cyto  c l  - 
Actin - -  
i~ . . . . . . . . . . . . . . . . . .  ~ ~ii ~ 
rRNA - -  
Fig. 2. Thyroid hormone induction of rat liver cytochrome c~ mRNA 
Northern blots were run on the RNA isolated from 8 rats; 4 hypothyroid 
( -T3)  and 4 hypothyroid given 3 daily injections of 20 /xg T3/100 g 
body weight (+T3). The poly(A)-enriched RNA was probed for cy- 
tochrome c~ and actin. Total RNA was probed for mitochondrial 12S 
rRNA. 
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Table 2 
Summary of the affects of thyroid hormone and growth activation on the 
expression of selected genes encoding mitochondrial inner membrane 
proteins 
Subunit Thyroid hormone Growth activation 
Complex III 
cytochrome c I + + + + + - 
Resike protein + + + 
core I 
cytochrome b + + + + 
Cytochrome oxidase 
subunit IV - - 
Subunit I + + + + 
ATPase 
/3-subunit - + + + 
DCCD-binding protein + + + 
Others 
ANT2 ++++ ++++ 
transhydrogenase + + 
fl-hydroxybutyrate dehydrogenase - 
Data taken from Refs. [2,3,13]. The gradation of induction is indicated by 
the number of ( + ) symbols. No response is indicated by ( - ). Absence of 
a symbol indicates that no measurements were made 
elements have been characterized which are believed to 
function specifically in the expression of respiratory chain 
or other OXPHOS genes. These include; NFR 1 [21,27], 
NRF 2 [22,28], OXBOX/REBOX [26,29] and the Mtl, 3 
and 4 boxes [23,30]. However, no OXPHOS genes charac- 
terized to date contain all of these elements. The 
OXBOX/REBOX is proposed to function as a muscle- 
specific element [29]. Specific functions of the remaining 3
elements are not known, though it has been suggested that 
NRF1, which is present in the human mtTFA and MR- 
PRNA genes, could regulate mitochondrial DNA replica- 
tion and/or transcription [31]. 
The heterogeneity of the regulatory elements of OX- 
PHOS genes becomes even more obvious from the data 
summarized in Fig. 5. The most thoroughly analyzed 
promoters to date are rat cytochrome c (Fig. 5B) and 
human cytochrome c~, mouse COX Vb, and rat and mouse 
COXIV (Fig. 5A). Although the basal promoter regions for 
ANT2 and the F 1 fl-subunit have not been established in 
detail, functional upstream elements have been experimen- 
+1 
[ ~ phCC1 (-Sb'7/+S1) 
I I Spl, AP1, Ets Pstl/Pstl (-567/-367) 
- - I  Spl - -  Ddel/Ddel (-476/-367) 
I j Sp1(2), Mr2, ENK, RBE, Ets(2) Banll/Banll (-462/-226) 
Spi(3). AP1, RBE 1 1  BssHll/Smal (-1391+61) 
Spl, API 
Spl. AP1 
Aval/Smal (-102/+61) 
Aval/Aval (-10~/+116) 
Band T3- Competed 
shi f t  responsive by Spl, AP1 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
Fig. 3. Thyroid hormone does not induce new nuclear factors that bind to the promoter region of the cytochrome c I gene. Nuclear extracts were prepared 
from the livers of hypothyroid and T3-treated rats. Protein binding to the promoter region of the cytochrome c t gene was analyzed by the electrophoretic 
gel mobility shift assay (EMSA) using the indicated restriction fragments as radiolabeled probes. Numbering is relative to the translational initiation site. 
The putative transfactor binding elements are indicated for each fragment. The number of times each element is repeated is shown in parentheses. The 
transfactors are defined in the text. Oligonucleotides containing core Spl (CCGCCC) or AP1 (TGACTCA) binding sites were used in competition 
experiments. All promoter f agments produced band shifts. Lack of induction of new complexes by T3, or lack of competition for binding by Spl and AP1 
oligonucleotides, are indicated by a minus sign ( - ) .  
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"/3 + + + 
Fig. 4. The cytochrome c~ promoter confers T3 induction of the CAT 
gene in transient transfection experiments. JEG-3 cells were transfected 
for 24 h in thyroid hormone-depleted serum. Transfection contained 10 
/xg of pCATbasic (Promega) with the 1.4 kb promoter egion of the 
human cytochrome c I gene inserted 5' of the CAT gene, 0.5 to 1.5 /xg of 
an expression vector carrying the chicken TRo~ gene, p~g of pCH110 
(Pharmacia) which expresses the /3-galactosidase g ne and is used as a 
measure of transfection efficiency, and pGEM to give a total of 20 p,g 
DNA. After transfection, cells were incubated an additional 48 h in the 
absence of presence (100 nM) of T3. 
tally demonstrated for these genes [32,33] (Fig. 5A). With 
the exception of the ANT2 and ANT1 genes, none of these 
OXPHOS genes so far investigated contain a TATA box. 
Thus, the elements urrounding transcription i itiation are 
important for basal transcription, and perhaps even regu- 
lated transcription. Fig. 5 shows that Spl is the only cis 
element which all of the genes have in common. However, 
the structure of the promoter, including the transfactor 
binding elements, vary considerably between the genes. 
This diversity of transfactor binding sites within the basal 
promoter strongly suggests that individual OXPHOS genes 
can be controlled in an independent, non-coordinated fash- 
ion. 
With the exception of the need for tissue-specific ex- 
pression of the isoforms of certain OXPHOS proteins 
[34,35], the physiological implications of multiple regula- 
tory circuits or promoter diversity is not clear. One possi- 
ble explanation is that certain subunits of each respiratory 
chain complex play central roles in organizing assembly of 
the complex. Rat liver cytochrome oxidase is, for example. 
assembled in an ordered and sequential fashion [36,37]. As 
such, it could be advantageous for the cell if synthesis of 
the core assembly subunits could be regulated. A variation 
of this concept might be that inner membrane complexes 
do not breakdown as a unit, but, rather, individual subunits 
turnover at different rates [38]. Subunits with highest 
turnover rates would most likely be limiting for the assem- 
bly of functional complexes, and, as such, could be the 
Table 3 
Promoter elements which regulate xpression of OXPHOS genes 
NRF1 (5'-((T/C)GCGGC(T/C)GCGC(T/G)-3') 
rat somatic ytochrome 
human somatic ytochrome c 
rat COXVIc-2 
bovine COXVIIa 
human ubiquinone binding protein 
bovine F I-ATPase 3' 
mouse MRP RNA 
human MRP RNA 
human mtTFA 
rat ALA synthase 
NRF2 (ets, GGAA) 
rat COXIV 
mouse COXVb 
A site 
B site 
A site 
B site 
C site 
D site 
human F I-ATPase /3-subunit 
OXBOX/REBOX (5'-GGCTCTAAAGAGG-3') 
human Fi-ATPase /3-subunit 
human ANTI 
Mtl (5'-TATTCAGGT-3'), Mt3 (5'-ATCTGGC-3'), Mt4 (TGGTGA(T/G)AG-3') 
Mtl 
human ubiquinone binding protein -626/ -  628 
human cytochrome c I - 1304/ -  1296 
human F I -ATPase J3-subunit - 1790/ -  1798 
rat cytochrome c - 660/ -  652 
- 173 / -  143 
- 176/ -  150  
- 46 / -  20 
-11 / -22  
- 46 / -  75 
+1/+20 
- 315/ -  289 
- 299/ -  273 
- 59 / -  70 
- 59 / -  70  
+11/+2 
+29/+20 
- 57 / -  48 
- 52 / -  43  
- 15 /+ 28 
+ 19/+ 28 
+ 599/+ 590 
- 560 
- 470 
Mt3 Mt4 
-726/ -  719 -592/ -  584 
- 1381/ -  1374 - 1284/ -  1292 
- 1798/ -  1791 - 1718/ -  1726 
- 685/ -  678 - 539/ -  547 
The numbers mark the location of the elements with respect to the transcriptional initiation site. Data are compiled from Refs. [21-23,26,27,30-34]. 
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-240  -220  -200 -180 -160 -140 -120 -100 -80 -60 -40 -20 +1 +20 +40 
I I f I I I I I I I I I I I I 
Spl RBE Spl Spl ~-  AP1 
F~F 
Human cyto cl 
Spl repeats Spl F-2F(Inr) 
I ~ : r l~ II~H" Mouse COXIV 
NRF2 NRF2 
AP4 AP1 Spl NRF2 N R ~ F 2  
m [ ]  r l  m 
Spl 
B 
-800 -700 -600 -500 -400 -300 -200 -100 +1 +100 +200 
, , , , , , . . . . . . . . . . . . . . .  
Mouse COXVb 
13 " = 
OX/REBOX CAAT x 4 
Sp l  x 2 N R ~ x 2  
[ ]  
Human FI-~ 
Rat  Cyto c 
OCT OCT CAAT Splx4 TATA t-I~- 
~] ~ [ ]  Human ANT2 [ ]B  
SP1 
Fig. 5. A summary of the promoter structures of some OXPHOS genes. Transcriptional initiation sites are indicated by arrows. The basal promoters of the 
genes in (A), as well as the cytochrome c gene (B), have been defined in detail. 
target of regulation of the level of gene expression. What- 
ever the case, it is clear the our understanding of the 
regulatory circuits must improve before we can start to 
screen for disease states caused by such defects. 
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